Successful management of a case of SARS‐CoV‐2 infection in an advanced Rheumatoid Arthritis patient by dose reduction of immunosuppressive medication

Abstract

<jats:title>Abstract</jats:title> <jats:p>Rheumatoid Arthritis (RA) patients usually managed with immunosuppressive agents and they are at a higher risk of infections. There are limited data regarding RA patients with COVID-19. This article reports a RA patient with an acute SARS‐CoV‐2 infection that successfully managed by dose reduction of immunosuppressive medication.</jats:p>